High Intensity Focused Ultrasound Market By Product Type (HIFU Systems, Accessories & Consumables, Software, Services), By Device Type (Extracorporeal, Endorectal Probes, Intercostal Approaches, Intra-operative Probes), By Technology (Ultrasound-Guided HIFU (USgHIFU), MRI-Guided HIFU (MRgFUS)), By Application (Oncology, Gynecology, Neurology, Urology, Aesthetic & Dermatology, Others), By End-User (Hospitals & Specialty Cancer Centers, Ambulatory Surgical Centers (ASCs), Research & Academic Institutes, Aesthetic & Dermatology Clinics, Others), Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles And Market Forecast, 2025 – 2035.
Published Date: Sep 2025 | Report ID: MI3633 | 220 Pages
What trends will shape High Intensity Focused Ultrasound Market in the coming years?
The High Intensity Focused Ultrasound Market accounted for USD 1.36 Billion in 2024 and USD 1.46 Billion in 2025 is expected to reach USD 2.96 Billion by 2035, growing at a CAGR of around 7.32% between 2025 and 2035. The High Intensity Focused Ultrasound Market will be highly dynamic due to the growing demand for non-invasive and minimally invasive therapy. Increased rates of chronic conditions like cancer and uterine fibroids will increase the rate of adoption, and the increase in precision and safety with technological improvements in ultrasound and MRI-guided systems. The combination of real-time imaging and AI is predicted to enhance the treatment results as well as the workflow. Increased consciousness between the patients and clinicians regarding the advantages of using HIFU as compared to the conventional surgery will enhance market penetration.
New growth opportunities will be generated in emerging economies that have an improved healthcare infrastructure. The partnership of medical device companies and research institutions will most probably drive innovation. Accessibility can further be improved by cost optimization and portable HIFU devices. The market, in general, is set to grow strongly and in the long term due to innovation and patient-centric solutions.
What do industry experts say about the High Intensity Focused Ultrasound market trends?
“This quarter, we hit a major inflection point for Focal One adoption. Awareness is the first step toward action,” emphasizing efforts to increase patient awareness of non-invasive prostate cancer treatment. He also noted, “Securing reimbursement in France is likely to accelerate reimbursement for Focal One Robotic HIFU in additional European countries.”
- Ryan Rhodes, CEO of EDAP TMS.
Which segments and geographies does the report analyze?
Parameter | Details |
---|---|
Largest Market | North America |
Fastest Growing Market | Asia Pacific |
Base Year | 2024 |
Market Size in 2024 | USD 1.36 Billion |
CAGR (2025-2035) | 7.32% |
Forecast Years | 2025-2035 |
Historical Data | 2018-2024 |
Market Size in 2035 | USD 2.96 Billion |
Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, Switzerland, Sweden, Finland, Netherlands, Poland, Russia, China, India, Australia, Japan, South Korea, Singapore, Indonesia, Malaysia, Philippines, Brazil, Argentina, GCC Countries, and South Africa |
What We Cover | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PESTLE analysis, value chain analysis, regulatory landscape, pricing analysis by segments and region, company Market share analysis, and 10 companies. |
Segments Covered | Product Type, Device Type, Technology, Application, End User, and Region |
To explore in-depth analysis in this report - Request Sample Report
What are the key drivers and challenges shaping the High Intensity Focused Ultrasound market?
What rising prevalence of cancer fuels adoption of non-invasive HIFU treatments globally?
The High Intensity Focused Ultrasound Market is a segment that has been experiencing robust growth worldwide as cancer prevalence increases and the need to find non-invasive methods of treatment is on the rise. In India, the Indian Council of Medical Research (ICMR) reported that the new cancer cases were more than 1.4 million in the year 2023, which needs to be addressed through advanced therapies. Compared to the traditional surgeries, HIFU is a safer procedure as it offers targeted treatment, which reduces the adverse effects on the surrounding healthy tissues. It is particularly attractive to those patients who want less traumatic forms of treatment due to its non-invasive nature.
The technology has been shown to be efficient in a variety of cancers, such as prostate, liver, and uterine, which increases the clinical use of the technology. HIFU procedures usually imply a lower healing time, which saves the amount of hospital time and the total healthcare cost. Patient awareness and acceptance are on the upswing, contributing to higher levels of adoption in the urban and semi-urban areas. Imaging and treatment planning improvements allow better accuracy in care, better treatment outcomes, and safety. Infrastructure development of health care facilities, as well as increasing disposable incomes, contributes to the expansion of the market. All in all, the introduction of HIFU is a sign of the global shift to more efficient and less painful cancer treatment.
How do technological advancements enhance precision and safety in focused ultrasound systems?
The High Intensity Focused Ultrasound Market is experiencing tremendous positive impacts due to the use of technology that facilitates better accuracy and safety of the treatment. Real-time imaging, which may be MRI and ultrasound, should also be incorporated to enable clinicians to precisely target the affected tissue and continuously monitor the procedure. Such targeting reduces the destruction of the surrounding healthy tissues, thereby tremendously reducing the likelihood of developing complications. Advancements in the design of transducers and electronic control systems are used to guarantee consistency and reliability of the energy delivery during procedures.
The TCM technologies can monitor the change in tissues in real-time and provide feedback on the heat effects, allowing the adjustment of therapeutic results. More advanced treatment planning and imaging guidance software further increase the accuracy of the procedure. All these technologies render HIFU less harmful, more efficient, and less invasive to patients with various types of diseases. The introduction of robotic-assisted and AI-based solutions is also contributing to consistency in the process and less reliance on operators. Ongoing research and innovation are coming up with more advanced solutions that are broadening clinical uses. In general, technology innovation has turned HIFU into a very accurate and safe non-invasive treatment method, which can be widely used in the global context.
How do high device costs limit accessibility and adoption across emerging healthcare markets?
High Intensity Focused Ultrasound Market is not accessible to the emerging healthcare markets because of the high cost of equipment. HIFU systems need sophisticated imaging equipment, accurate transducers, and special software that make the process costly when initially acquiring them for hospitals and clinics. The costs of maintenance, calibration, and consumables are an extra burden to the overall financial cost, which restricts its use in areas with a sensitive cost factor. Smaller hospitals and those in rural areas are not always able to afford such equipment that is as high-end. Poor insurance coverage and reimbursement of HIFU procedures are other factors that deter healthcare providers from using the technology.
The cost of the devices is also high, thus limiting the access of patients who can afford the out-of-pocket expenses. As a result, uptake in the emerging economies is still low in comparison to the developed economies. These economic obstacles cause differences in access to non-invasive cancer and cosmetic procedures. Cost cutting in terms of portable devices or local production is underway, and it has not yet addressed the problem of accessibility completely. On the whole, high prices continue to be one of the primary limiting factors that discourage mass HIFU usage in developing healthcare industries.
How can portable HIFU devices expand treatment access in rural and underserved regions?
The High Intensity Focused Ultrasound (HIFU) Market can contribute to the significant growth of the treatment market in rural and underserved areas with the use of portable HIFU devices. To provide primary healthcare services to remote locations, there are more than 1.6 lakh functioning Health and Wellness Centres (AB-HWCs) in India. These centers act as a focal point for early diagnosis and treatment of different diseases. HIFU machines can be implemented in these facilities to administer non-invasive solutions to the cancers, uterine fibroids, and other medical conditions. Their portability and small size allow them to be used in any place with no specialized medical facilities.
Portable systems are affordable and are therefore feasible in smaller healthcare centers with smaller budgets. Patients enjoy the advantage of having shorter travel requirements, thereby reducing the cost and time limits that come with urban treatment centers. Tie-in to telemedicine sites and remote consultations and procedure guidance can be provided, increasing the efficiency of treatment. By providing local and advanced therapies, healthcare providers are able to enhance patient outcomes by delivering them at the local level. In general, portable HIFU devices are a key to the healthcare access situation in underserved areas.
What potential exists for combining AI and imaging to improve treatment outcomes?
The combination of Artificial Intelligence (AI) and advanced imaging technologies is an important addition to the High Intensity Focused Ultrasound (HIFU) Market that can improve the outcomes of the treatment. Medical pictures can be examined by AI algorithms with remarkable accuracy, including the identification of subtle abnormalities, which might otherwise be overlooked by the human clinician. This feature encourages early diagnosis and allows the planning of the individual treatment of complex conditions. In India, it has been suggested that high-quality standardized medical datasets be created under the Medical Imaging Datasets for India (MIDAS) project under ICMR and IISc to train AI models specific to the Indian population.
Using these datasets, AI can forecast disease development, streamline care regimes, and check on patient outcomes in real time. The use of AI-assisted imaging during HIFU procedures will enable the creation of detailed anatomical maps that allow the accurate targeting of the area and minimum harm to healthy tissue. This integration enhances the efficacy, safety, and patient satisfaction. Higher imaging with the support of AI will enable clinicians to make adjustments to their treatments in real-time, improving the accuracy of therapy. Procedural variability and operator dependency are also lowered with the introduction of AI-assisted HIFU. In general, a combination of AI and imaging technologies is turning out to make HIFU a highly tailored, safe, and patient-centric treatment modality.
What are the key market segments in the High Intensity Focused Ultrasound industry?
Based on the product type, the High Intensity Focused Ultrasound Market is classified into HIFU Systems, Accessories & Consumables, Software, and Services. HIFU systems have the highest proportion because they are required more because patients are becoming more demanding on the need to get non-invasive treatment in the fields of oncology, gynecology, and aesthetic services. Accessories and consumables are used to facilitate effective functioning of the system and continuity in clinical procedures, which generates and maintains consistent sources of revenue.
The software is vital in planning the treatment, guiding the imaging, and monitoring the patients in real-time to improve the accuracy and safety of the patients. There are installation, maintenance, training, and consulting services, which guarantee maximum system performance and adoption. Increasing awareness amongst medical professionals of the advantages of minimally invasive procedures also promotes the use of HIFU systems. The application of AI in treating imaging software and technological progress improves treatment outcomes and efficiency of the process. All in all, the product type segmentation indicates the potential of the revenue and innovation opportunities in the global High Intensity Focused Ultrasound Market.
Based on the application, the High Intensity Focused Ultrasound Market is classified into Oncology, Gynecology, Neurology, Urology, Aesthetic & Dermatology, and Others. In the market, oncology is leading since HIFU offers a non-invasive therapy for prostate, liver, and breast cancers and targets the tumors precisely. The uses of gynecology are related to the treatment of uterine fibroids and adenomyosis, which provides patients with safer and less invasive forms of treatment. HIFU is employed by neurology to treat such diseases as essential tremor and Parkinson's disease, improving the quality of life of patients.
Urology uses HIFU in cases of prostate-related disorders, which minimizes the surgical risks and heals faster. Applications in aesthetics and dermatology, such as facial lifting, wrinkles, and body contours, are becoming more popular in non-surgical cosmetic surgery. The other segment consists of orthopedic, ophthalmology, and cardiology applications that represent new research and adoption. Ongoing technological progress and increasing patient awareness are catalysts of growth in these areas of application. All in all, the application segmentation outlines the wide range of therapeutic and cosmetic opportunities of the High Intensity Focused Ultrasound Market across the world.
Which regions are leading the High Intensity Focused Ultrasound market, and why?
The North America High Intensity Focused Ultrasound Market is leading due to the popularity of new technologies and well-developed healthcare facilities. The dominance of the region is by the United States, which is backed up by powerful research efforts, good reimbursement policies, and increasing awareness of noninvasive therapies. Another area in which Canada can contribute to the growth of the market is by further investing in oncology and aesthetic treatment centers.
The existence of the major market players, including EDAP TMS S.A. and INSIGHTEc Ltd., helps to reinforce the competition in the region. The growing trend of chronic diseases, such as cancer and neurological diseases, generates the need to provide HIFU treatments. The level of technologizing ultrasound and MRI-guided systems improves the accuracy and patient outcomes, which increases their adoption. The safety and effectiveness of HIFU procedures is guaranteed by the attention to the regulatory compliance and clinical trials in North America. On the whole, the region continues to contribute significantly to revenues and is a center of innovation in the global High Intensity Focused Ultrasound Market.
The Asia Pacific High Intensity Focused Ultrasound Market is growing due to the development of better healthcare facilities and increased awareness of patients. The use of HIFU technologies is fast being adopted in countries like China, Japan, and India in the fields of oncology, gynecology, and aesthetics. The increasing prevalence of chronic diseases such as cancer and uterine fibroids drives the need to find a non-invasive way of treatment. Government programs and good reimbursement policies favor the growth of sophisticated medical centers and treatment centers.
The growth of investments made by international and national manufacturers of HIFU devices enhances the level of rivalry and market presence. The accessibility of this technology in urban and semi-urban areas is increased by technological development and low-priced, portable HIFU systems. Disposable incomes and increased health insurance coverage are further increasing adoption in both the private and the government hospitals. In general, Asia-Pacific is a sector that offers massive growth potential, thus being a major contributor to the expansion of the High Intensity Focused Ultrasound Market across the world.
What does the competitive landscape of the High Intensity Focused Ultrasound market look like?
The High Intensity Focused Ultrasound Market in the world is experiencing dynamic growth, owing to the development of technology and its growing use of noninvasive treatment methods. To reinforce its stance, EDAP TMS S.A. has installed several Focal One Robotic HIFU Systems and ensured reimbursement in major countries in Europe, which enhances accessibility for prostate cancer patients. With its Exablate platform, INSIGHTEC Ltd. continues to be a pioneer in the MRI-guided HIFU technology and has extended its application in the crucial tremor and Parkinson diseases. SonaCare Medical has been left with Sonablate system in focus and the world has accepted it in terms of clinical incidences and academic collaborations. Haifu Medical is promoting the use of HIFU in Asia, both in oncology and aesthetics.
Sofwave Medical is pioneering in the aesthetic and dermatology sector, where new applicators have been launched in non-invasive skin treatments. The market is being embraced more in the emerging economies with the advancement in the healthcare infrastructure and the increase in the knowledge of the minimally invasive procedures. Combining AI and imaging software is improving accuracy, treatment design, and patient outcomes. Innovation and increased global coverage are being fuelled by strategic collaborations and partnerships among key players. Overall, there is increasing competition in the High Intensity Focused Ultrasound Market, with companies opting to dominate technology, clinical validation, and an expansive market allocation.
High Intensity Focused Ultrasound Market, Company Shares Analysis, 2024
To explore in-depth analysis in this report - Request Sample Report
Which recent mergers, acquisitions, or product launches are shaping the High Intensity Focused Ultrasound industry?
- In August 2025, EDAP TMS announced its best-ever second quarter by placing 12 Focal One Robotic HIFU systems, driven by strong demand in the U.S. and international markets. This performance is further supported by a 76.8% year-over-year increase in HIFU revenue and a raised full-year HIFU growth forecast to 26-34%, signaling accelerating momentum for their leading Focal One platform.
- In June 2025, the U.K.'s National Health Service became Europe's first healthcare system to roll out the Edison histotripsy device, offering liver cancer patients access to incision-free tumor ablation. This initiative signals the NHS's intent to fast-track novel focused-ultrasound therapies.
- In March 2025, Chongqing Haifu Medical completed the first international 5G-remote HIFU surgery, highlighting the viability of tele-mentoring in medical procedures. This milestone underscores the company's leadership in advancing HIFU technology.
Report Coverage:
By Product Type
- HIFU Systems
- Accessories & Consumables
- Software
- Services
By Device Type
- Extracorporeal
- Endorectal probes
- Intercostal approaches
- Intra-operative probes
By Technology
- Ultrasound-Guided HIFU (USgHIFU)
- MRI-Guided HIFU (MRgFUS)
By Application
- Oncology
- Gynecology
- Neurology
- Urology
- Aesthetic & Dermatology
- Others
By End-User
- Hospitals & Specialty Cancer Centers
- Ambulatory Surgical Centers (ASCs)
- Research & Academic Institutes
- Aesthetic & Dermatology Clinics
- Others
By Region
North America
- U.S.
- Canada
Europe
- U.K.
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
List of Companies:
- EDAP TMS S.A.
- SonaCare Medical, LLC
- Chongqing Haifu Medical Technology Co., Ltd.
- INSIGHTEC Ltd.
- Sofwave Medical Ltd.
- Theraclion S.A.
- Alpinion Medical Systems Co., Ltd.
- Focus Surgery Ltd.
- Medi-Tate Co., Ltd.
- AccuVein, Inc.
- Ulthera, Inc.
- Shenzhen HIFU Technology Co., Ltd.
- Terason, Inc.
- Tianjin HIFU Medical Technology Co., Ltd.
- BioEcho Technologies, Inc.
Frequently Asked Questions (FAQs)
The High Intensity Focused Ultrasound Market accounted for USD 1.36 Billion in 2024 and USD 1.46 Billion in 2025 is expected to reach USD 2.96 Billion by 2035, growing at a CAGR of around 7.32% between 2025 and 2035.
Key growth opportunities in the High Intensity Focused Ultrasound Market include portable HIFU devices enable non-invasive treatments, increasing accessibility in rural underserved regions, combining AI and imaging enhances precision, improving patient outcomes and treatment effectiveness, and emerging economies with better healthcare infrastructure create significant opportunities for HIFU market growth.
In the High Intensity Focused Ultrasound Market, HIFU Systems dominate, while Ultrasound-Guided HIFU and Oncology applications grow fastest globally.
North America contributes most to the High Intensity Focused Ultrasound Market, with Asia-Pacific showing the fastest growth globally.
Key operating players in the High Intensity Focused Ultrasound Market are EDAP TMS S.A., SonaCare Medical, INSIGHTEC Ltd., Haifu Medical, Sofwave Medical.
Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!
Our analysts are ready to help you immediately.